AUGMENTIN ES-600 Drug Patent Profile
✉ Email this page to a colleague
When do Augmentin Es-600 patents expire, and what generic alternatives are available?
Augmentin Es-600 is a drug marketed by Us Antibiotics and is included in one NDA.
The generic ingredient in AUGMENTIN ES-600 is amoxicillin; clavulanate potassium. There are forty-six drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the amoxicillin; clavulanate potassium profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Augmentin Es-600
A generic version of AUGMENTIN ES-600 was approved as amoxicillin; clavulanate potassium by SANDOZ on March 14th, 2002.
Summary for AUGMENTIN ES-600
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 15 |
| Clinical Trials: | 74 |
| Patent Applications: | 705 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in AUGMENTIN ES-600? | AUGMENTIN ES-600 excipients list |
| DailyMed Link: | AUGMENTIN ES-600 at DailyMed |
Recent Clinical Trials for AUGMENTIN ES-600
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University Hospital, Limoges | Phase 2 |
| Cairo University | Early Phase 1 |
| Western Sydney Local Health District | Phase 2 |
Pharmacology for AUGMENTIN ES-600
| Drug Class | Penicillin-class Antibacterial beta Lactamase Inhibitor |
| Mechanism of Action | beta Lactamase Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for AUGMENTIN ES-600
US Patents and Regulatory Information for AUGMENTIN ES-600
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Us Antibiotics | AUGMENTIN ES-600 | amoxicillin; clavulanate potassium | FOR SUSPENSION;ORAL | 050755-001 | Jun 22, 2001 | AB | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
